Health
Study characterizes cisplatin-induced hearing loss in pediatric cancer patients – News-Medical.Net
Cisplatin is one of the most effective chemotherapy agents, used in just under half of pediatric cancer cases.
Cisplatin is one of the most effective chemotherapy agents, used in just under half of pediatric cancer cases. Permanent hearing loss is a common side effect of this medication, but until now, studies have been too small and too varied to accurately characterize this risk.
Today in The Lancet Child & Adolescent Health, investigators at Children’s Hospital Los Angeles published results of the largest study of cisplatin-induced hearing loss to date. The study establishes the first benchmarks for the…
-
Business11 hours agoCould a small investor today match the historic returns of Warren Buffett?
-
Noosa News24 hours agoBasic cyber steps can block most attacks – Proctor
-
Noosa News18 hours agoWhat instrument did Japan’s heavy-metal PM play? Take the Brisbane Times Quiz
-
Noosa News21 hours agoFamily ‘quite nasty’ to woman who married step-uncle before his alleged murder, court hears